Fig. 3
Changes in HOMA-IR (A), ALT (B), LFC (C), liver stiffness (D) in the groups classified by changes in weight and ASM/W. ASM, appendicular skeletal mass; ASM/W, ASM/weight; HOMA-IR, homeostatic model assessment of insulin resistance. Weight loss was defined as â–³weight>0. â–³weight=weight Baseline-Follow-up. The ASM/W increase was determined to be â–³ASM/W>0. â–³ASM/W =ASM/W Follow-up-Baseline. WL-, without weight loss; WL+, with weight loss; ASM/WI-, without ASM/W increase; ASM/WI +, with ASM/W increase. *P<0.05; **P<0.01; ***P<0.001; ns, not significant